Supplemental material, sj-doc-1-tab-10.1177_1759720X221124028 for Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis by Marta Novella-Navarro, Diego Benavent, Virginia Ruiz-Esquide, Carolina Tornero, Mariana Díaz-Almirón, Chafik Alejandro Chacur, Diana Peiteado, Alejandro Villalba, Raimon Sanmartí, Chamaida Plasencia-Rodríguez and Alejandro Balsa in Therapeutic Advances in Musculoskeletal Disease</p
Supplemental material, sj-docx-2-tab-10.1177_1759720X221122401 for High inflammatory burden predicts...
Supplemental material, sj-docx-3-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...
Supplemental material, sj-docx-4-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...
Supplemental material, sj-docx-1-tab-10.1177_1759720X221114103 for Characterization of missing data ...
Supplemental material, sj-doc-1-jtt-10.1177_1357633X221122098 for Impact of a hybrid medical care mo...
Supplemental material, sj-docx-1-tab-10.1177_1759720X231197087 for Treatment with adalimumab in pati...
<p>Supplemental material, DS_10.1177_0272989X18775975 for Prediction of Real-World Drug Effectivenes...
Supplemental material, sj-docx-1-tab-10.1177_1759720X221114105 for Plasma calprotectin as a biomarke...
Supplemental material, sj-docx-3-amd-10.1177_11795441231213887 for Patient-Reported Outcome Measures...
Supplemental material, sj-docx-1-amd-10.1177_11795441231213887 for Patient-Reported Outcome Measures...
Contains fulltext : 19266_decisuint.pdf (publisher's version ) (Open Access)Rheuma...
Supplemental material, sj-docx-1-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...
Supplemental material, sj-docx-1-tab-10.1177_1759720X221122401 for High inflammatory burden predicts...
Supplemental material, sj-docx-2-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...
Supplemental material, sj-docx-5-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...
Supplemental material, sj-docx-2-tab-10.1177_1759720X221122401 for High inflammatory burden predicts...
Supplemental material, sj-docx-3-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...
Supplemental material, sj-docx-4-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...
Supplemental material, sj-docx-1-tab-10.1177_1759720X221114103 for Characterization of missing data ...
Supplemental material, sj-doc-1-jtt-10.1177_1357633X221122098 for Impact of a hybrid medical care mo...
Supplemental material, sj-docx-1-tab-10.1177_1759720X231197087 for Treatment with adalimumab in pati...
<p>Supplemental material, DS_10.1177_0272989X18775975 for Prediction of Real-World Drug Effectivenes...
Supplemental material, sj-docx-1-tab-10.1177_1759720X221114105 for Plasma calprotectin as a biomarke...
Supplemental material, sj-docx-3-amd-10.1177_11795441231213887 for Patient-Reported Outcome Measures...
Supplemental material, sj-docx-1-amd-10.1177_11795441231213887 for Patient-Reported Outcome Measures...
Contains fulltext : 19266_decisuint.pdf (publisher's version ) (Open Access)Rheuma...
Supplemental material, sj-docx-1-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...
Supplemental material, sj-docx-1-tab-10.1177_1759720X221122401 for High inflammatory burden predicts...
Supplemental material, sj-docx-2-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...
Supplemental material, sj-docx-5-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...
Supplemental material, sj-docx-2-tab-10.1177_1759720X221122401 for High inflammatory burden predicts...
Supplemental material, sj-docx-3-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...
Supplemental material, sj-docx-4-tab-10.1177_1759720X231187189 for Drug switching in axial spondyloa...